The disease is classified based on histological grading, tumor stage, and the expression of key biomarkers such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [4,5,6]. This evidence concerns the gene ERBB2 and neoplasm.